ArticleCancer biology & therapy2024

S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective study.

Xin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.